Johnson & Johnson Profile Avatar - Palmy Investing

Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby br…

Drug Manufacturers - General
US, New Brunswick [HQ]
Financials

Analysts

Reported
Past Estimate Consensus
Future Estimate Consensus
EPS Revenue EBITDA EBIT SGA
Download
FY EPS Revenue [mil.] Profit [mil.] EBITDA [mil.] EBIT [mil.] Expenses · SGA [mil.]
E E E E E E
2014 4.9000 5.490 71,312 71,430 13,831 15,620 19,537 23,915 18,957 20,229 21,830 21,073
2015 5.8600 6.182 74,331 70,109 16,323 15,828 21,315 23,456 21,137 17,260 21,954 17,772
2016 5.5700 6.706 70,074 72,022 15,409 17,170 19,022 24,096 18,289 17,731 21,203 18,257
2017 6.0800 7.278 71,890 76,260 16,540 18,633 21,685 25,514 21,165 18,774 19,945 19,331
2018 0.4800 8.164 76,450 81,399 1,300 20,901 19,839 27,233 19,122 20,039 21,420 20,633
2019 5.7500 8.669 81,581 82,128 15,297 14,617 22,552 23,819 21,175 20,203 22,540 21,427
2020 5.7200 7.996 82,059 81,795 15,119 15,688 22,126 24,619 20,970 18,507 22,178 20,284
2021 5.5900 9.832 82,584 94,449 14,714 17,256 20,342 27,081 19,914 20,357 22,084 22,313
2022 7.9300 10.046 93,775 95,018 20,878 18,982 25,699 29,789 24,547 22,393 24,659 24,544
2023 6.8300 9.918 94,943 84,746 17,941 13,326 24,024 32,768 23,703 24,633 24,765 26,998
2024 14.6000 9.942 85,152 88,734 35,153 25,455 29,339 29,687 21,853 21,845 21,512 22,493
2025 - 10.575 - 91,348 - 26,679 - 30,562 - 22,489 - 23,155
2026 - 2.F12X/td> - 2.F12X/td> - 2.F12X/td> - 2.F121/td> - 2.F121 - 2.F121
2027 - 1.F13X/td> - 1.F13X/td> - 1.F13X/td> - 1.F131/td> - 1.F131 - 1.F131
2028 - 0.F14X/td> - 0.F14X/td> - 0.F14X/td> - 0.F141/td> - 0.F141 - 0.F141
End of JNJ's Analysis
CIK: 200406 CUSIP: 478160104 ISIN: US4781601046 LEI: - UEI: -
Secondary Listings
XETRA:JNJ.DE